N-(4-methoxyphenyl)-N-butyl-(3-(naphthalen-2-yloxy) propyl) amine

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: N-(4-methoxyphenyl)-N-butyl-(3-(naphthalen-2-yloxy) propyl) amine
• 英文别名: N-(4-methoxyphenyl)-N-butyl-(3-(naphthalen-2-yloxy)propyl)amine；N-(4-methoxyphenyl)-N-butyl-[3-(naphthalen-2-yloxy)propyl]amine；N-butyl-4-methoxy-N-(3-naphthalen-2-yloxypropyl)aniline
• 化学式: C₂₄H₂₉NO₂
• 分子量: 363.5
• InChiKey: ROQSZNSMJGPIEE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.5
• 重原子数：
  27
• 可旋转键数：
  10
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  21.7
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  N-(4-Methoxyphenyl)-[3-(naphthalen-2-yloxy)propyl]amine 、 1-碘丁烷 在 n-hexane benzene 作用下， 以 丙酮 为溶剂， 反应 12.0h， 以to get N-(4-methoxyphenyl)-N-butyl-(3-(naphthalen-2-yloxy) propyl) amine crystallized yellow solid, m.p. 127° C., (yield 0.78 gm, 98%)的产率得到N-(4-methoxyphenyl)-N-butyl-(3-(naphthalen-2-yloxy) propyl) amine
  参考文献：
  名称：

  Alpha-substituted naphthyloxy omega-substituted alkyl/aryl amino-substituted alkane derivatives as agent for treatment or prophylaxis of diabetes and related metabolic disorders

  摘要：

  本发明涉及一种新型的{overscore(&ohgr;)}-取代萘氧基氨基烷，其制备及用作降低血糖药物和用于治疗和预防心血管疾病（CVS）如降低脂质的作用。

  公开号：

  US20040192688A1

文献信息

• [EN] OMEGA-SUBSTITUTED-NAPHTHYLOXYALKLAMINO DERIVATIVES AS ANTIHYPERGLYCEMIC AGENTS AND PREPARATION<br/>[FR] DERIVES NAPHTYLOXYALKYLAMINO OMEGA-SUBSTITUES A TITRE D'AGENTS ANTIHYPERGLYCEMIQUES, ET LEUR PREPARATION
  申请人：COUNCIL SCIENT IND RES

  公开号：WO2005042465A1

  公开（公告）日：2005-05-12

  This invention relates to novel o-substituted-naphthyloxy-amino alkanes, their preparation and use as antihyperglycemic agents and for the treatment and prevention of cardiovascular disorders (CVS) such as lipid-lowering effects.

  本发明涉及新型的o-取代-萘氧基-氨基烷烃，其制备和用作降血糖药物以及用于治疗和预防心血管疾病（CVS）如降脂效果。
• Alpha-substituted naphthyloxy omega-substituted alky/aryl amino-substituted alkane derivatives as agent for treatment or prophylaxis of diabetes and related metabolic disorders
  申请人：Council of Scientific and Industrial Research

  公开号：US07081465B2

  公开（公告）日：2006-07-25

  This invention relates to novel overscore (ω)}-substituted-naphthyloxy-amino alkanes, their preparation and use as antihyperglycemic agents and for the treatment and prevention of cardiovascular disorders (CVS) such as lipid lowering effects.

  该发明涉及新型overscore (ω)}-取代-萘氧基-氨基烷，其制备以及作为抗高血糖药物和用于治疗和预防心血管疾病（CVS）如降脂作用的用途。
• ω-(2-Naphthyloxy) amino alkanes as a novel class of anti-hyperglycemic and lipid lowering agents
  作者：Devdutt Chaturvedi、Suprabhat Ray、Arvind K. Srivastava、Ramesh Chander

  DOI：10.1016/j.bmc.2007.11.062

  日期：2008.3

  omega-(2-Naphthyloxy) amino alkanes, obtained as major by-product during course of synthesis of carbamate esters from omega-(2-naphthyloxy) alkyl halides and amines, showed significant anti-hyperglycemic and lipid lowering activities in various test models as a novel class of compounds. Compounds were tested in rat GLM, SLM, STZ, and STZ-S models at 100 mg/kg dose. Of these compound 13 was found to be the most active which caused lowering of sugar by 33.6%, 31.0%, 28.5%, and 73.8% in GLM, SLM, STZ, STZ-S, and db/db mice models, respectively. It also significantly effected lowering of LDL in rat model and also in Hamster model without reducing HDL. Most of the compounds showing anti-diabetic and lipid lowering activity have shown promising PPAR-alpha/beta/gamma-activity. Compounds 6, 13, and 19 have shown very good PPAR-alpha/beta/gamma activity. (C) 2007 Elsevier Ltd. All rights reserved.
• OMEGA-SUBSTITUTED-NAPHTHYLOXYALKLAMINO DERIVATIVES AS ANTIHYPERGLYCEMIC AGENTS AND PREPARATION
  申请人：COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH

  公开号：EP1682484A1

  公开（公告）日：2006-07-26
• US7081465B2
  申请人：——

  公开号：US7081465B2

  公开（公告）日：2006-07-25